🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

eJHaem(2020)10.1002/jha2.1Source: DataRank Database

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes? is a research paper published in eJHaem (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (8)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Chelsea C. Pinnix ORCID,Gordon Glober ORCID,Kaitlin M. Christopherson ORCID,Penny Fang ORCID,Hun Ju Lee ORCID

Live enrichment

PubMed:32864660 PMC:PMC7455016

National Institutes of Health National Cancer Institute, Cancer Center Support

Grant: CA 016672

NCI NIH HHS

Grant: P30 CA016672

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.1

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjha2.1

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.1

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jha2.1

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7455016

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Hodgkins lymphomaShort ReportsDiseases of the blood and blood-forming organsRC633-647.5chemotherapyradiotherapy

Sustainable Development Goals

SDG 3: 3. Good health